P1.01-69 Validation of the Lung Immune Prognostic Index (LIPI): Useful to Identify Resistance to PD-1 Checkpoint Inhibitors in Pretreated Lung Cancer

Autor: Mielgo-Rubio, X., Sereno Moyano, M., Sotelo-Lezama, M., Lopez Castro, R., Rubio-Martínez, J., Velastegui, A., Olier-Garate, C., Falagan, S., Gómez-Barreda, I., Riquelme, A., Cardeña-Gutiérrez, A., Moreno Rubio, J., López, C., Bueno, C., Silva-Ruiz, J., Zhan Zhou, E., Chara, L.
Zdroj: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S488-S489
Databáze: ScienceDirect